7Baggers
 Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2025 Earnings Call Transcript  Insider Monkey Sat, 15 Nov 2025 13:18:07 GMT
 Iterum Therapeutics Reports Q3 2025 Financial Results  TipRanks Sat, 15 Nov 2025 04:09:28 GMT
 Iterum Therapeutics’ Earnings Call: Optimism Amid Challenges  TipRanks Sat, 15 Nov 2025 00:33:30 GMT
 Iterum Therapeutics sees cash runway into 2Q26  TipRanks Fri, 14 Nov 2025 15:35:41 GMT
 iterum therapeutics (itrm) earnings transcript  The Motley Fool Fri, 14 Nov 2025 14:13:00 GMT
 Iterum Therapeutics (ITRM) Projects Funding into Q2 2026  GuruFocus Fri, 14 Nov 2025 12:52:08 GMT
 Iterum Therapeutics (ITRM) Reports Revenue Surge with ORLYNVAH L  GuruFocus Fri, 14 Nov 2025 12:52:08 GMT
 Iterum Therapeutics plc SEC 10-Q Report  TradingView Fri, 14 Nov 2025 12:33:00 GMT
 Iterum Therapeutics Reports Third Quarter 2025 Financial Results  Yahoo Finance Fri, 14 Nov 2025 12:00:00 GMT
 A Glimpse of Iterum Therapeutics's Earnings Potential  Benzinga Thu, 13 Nov 2025 15:04:11 GMT
 iterum therapeutics(itrm.us) officer buys us$15,863 in common stocks  富途牛牛 Sun, 02 Nov 2025 07:00:00 GMT
 published on: 2025-10-29 21:40:27  newser.com Thu, 30 Oct 2025 02:40:27 GMT
 published on: 2025-10-28 17:51:32  Fundação Cultural do Pará Tue, 28 Oct 2025 20:51:32 GMT
 published on: 2025-10-27 20:47:27  newser.com Tue, 28 Oct 2025 01:47:27 GMT
 published on: 2025-10-25 04:14:50  newser.com Sat, 25 Oct 2025 09:14:50 GMT
 published on: 2025-10-21 02:54:40  newser.com Tue, 21 Oct 2025 07:54:40 GMT

Iterum Therapeutics plc
(NASDAQ:ITRM) 

ITRM stock logo

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials ...

Founded: 2015
Full Time Employees: 44
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends